Related Experiment Videos
[Sex-specific antihypertensive drug therapy]
Petra Pühringer1, Ghazaleh Gouya, Berthold Reichardt
1Universitätsklinik für Klinische Pharmakologie, Medizinische Universität Wien, Wien, Austria.
This study found significant sex-specific differences in hypertension medication prescriptions. Men and women received different classes of antihypertensives, indicating varied treatment patterns.
Area of Science:
- Cardiology
- Pharmacology
- Public Health
Background:
- Hypertension is a primary driver of cardiovascular diseases globally.
- Understanding sex-specific treatment variations is crucial for effective hypertension management.
- Regional health insurance data provides insights into prescription patterns.
Purpose of the Study:
- To investigate sex-specific differences in antihypertensive medication prescriptions.
- To analyze prescription patterns based on drug classifications in a large cohort.
Main Methods:
- Retrospective cross-sectional cohort study.
- Analysis of registry data from 41,499 individuals insured by the Burgenländische Gebietskrankenkasse (BGKK) in 2003.
- Evaluation of cardiovascular drug prescription data according to drug classifications.
Main Results:
- Females constituted 61.7% and males 38.3% of individuals on cardiovascular medication.
- Drugs acting on the renin-angiotensin system were most frequently prescribed.
- Women were more often prescribed diuretics and beta-blockers, while men received more antihypertensives and renin-angiotensin system drugs (p < 0.01).
Conclusions:
- Significant sex-specific differences exist in the prevalence and patterns of antihypertensive drug prescriptions.
- Equivalently effective antihypertensive medications are prescribed differently between men and women.
- These findings highlight the need for tailored hypertension treatment strategies considering sex-based variations.
Related Concept Videos
Hypertension IV: Drug Therapy and Lifestyle Modifications
Antihypertensive Drugs: Vasodilators
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Antihypertensive Drugs: Thiazide-Class Diuretics
Antihypertensive Drugs: Direct Renin Inhibitors
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...